Variant report

Variant	esv14874
Chromosome Location	chr6:29941757-29942849
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:9)
CpG islands
(count:244)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:9 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	E2F6	chr6:29942686-29943660	H1-hESC	embryonic stem cell:	n/a	n/a
2	POLR2A	chr6:29936914-29943239	K562	blood:	n/a	n/a
3	POLR2A	chr6:29942628-29942801	HepG2	liver:	n/a	n/a
4	POLR2A	chr6:29942266-29942585	K562	blood:	n/a	n/a
5	POLR2A	chr6:29942588-29942676	K562	blood:	n/a	n/a
6	SIN3A	chr6:29942645-29943161	H1-hESC	embryonic stem cell:	n/a	n/a
7	TBP	chr6:29942741-29943001	H1-hESC	embryonic stem cell:	n/a	n/a
8	ZNF143	chr6:29942558-29943168	H1-hESC	embryonic stem cell:	n/a	chr6:29942794-29942813
9	ZNF143	chr6:29942770-29942853	K562	blood:	n/a	chr6:29942794-29942813

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:29942083-29942133	AG09309	skin:	n/a
2	chr6:29942083-29942133	NT2-D1	testis:	n/a
3	chr6:29941917-29941967	MCF-7	breast:	n/a
4	chr6:29942505-29942555	HEK293	kidney:	embryo
5	chr6:29941917-29941967	BJ	skin:	n/a
6	chr6:29942083-29942133	AG09319	gingival:	n/a
7	chr6:29942706-29942756	AG09319	gingival:	n/a
8	chr6:29942083-29942133	A549	lung:	n/a
9	chr6:29942505-29942555	NB4	blood:	n/a
10	chr6:29942083-29942133	ECC-1	luminal epithelium:	n/a
11	chr6:29942706-29942756	AG04449	skin:	fetal
12	chr6:29942083-29942133	NHBE	bronchial:	n/a
13	chr6:29942505-29942555	PANC-1	pancreas:	n/a
14	chr6:29942706-29942756	RPTEC	kidney:	n/a
15	chr6:29941917-29941967	AoSMC	blood vessel:	n/a
16	chr6:29941917-29941967	U87	brain:	n/a
17	chr6:29942706-29942756	HPAEpiC	pulmonary alveolar:	n/a
18	chr6:29941917-29941967	HRCEpiC	kidney:	n/a
19	chr6:29942505-29942555	K562	blood:	n/a
20	chr6:29941917-29941967	K562	blood:	n/a
21	chr6:29942083-29942133	T-47D	breast:	n/a
22	chr6:29942505-29942555	SK-N-SH	brain:	n/a
23	chr6:29942505-29942555	BJ	skin:	n/a
24	chr6:29942706-29942756	A549	lung:	n/a
25	chr6:29942706-29942756	PrEC	prostate:	n/a
26	chr6:29942706-29942756	Hela-S3	cervix:	n/a
27	chr6:29942706-29942756	GM19239	blood:	n/a
28	chr6:29942706-29942756	GM06990	blood:	n/a
29	chr6:29941917-29941967	PFSK-1	brain:	n/a
30	chr6:29941917-29941967	PrEC	prostate:	n/a
31	chr6:29942083-29942133	Caco-2	colon:	n/a
32	chr6:29942083-29942133	H1-hESC	embryonic stem cell:	embryo
33	chr6:29942706-29942756	HCT-116	colon:	n/a
34	chr6:29942706-29942756	SK-N-SH_RA	brain:	n/a
35	chr6:29941917-29941967	SAEC	small airway:	n/a
36	chr6:29941917-29941967	HL-60	blood:	n/a
37	chr6:29941917-29941967	SK-N-SH_RA	brain:	n/a
38	chr6:29942505-29942555	MCF-7	breast:	n/a
39	chr6:29941917-29941967	HIPEpiC	eye:	n/a
40	chr6:29942083-29942133	Hela-S3	cervix:	n/a
41	chr6:29942706-29942756	AG09309	skin:	n/a
42	chr6:29942706-29942756	NB4	blood:	n/a
43	chr6:29942505-29942555	ECC-1	luminal epithelium:	n/a
44	chr6:29941917-29941967	GM19239	blood:	n/a
45	chr6:29942505-29942555	PFSK-1	brain:	n/a
46	chr6:29942706-29942756	HRPEpiC	eye:	n/a
47	chr6:29942706-29942756	MCF10A-Er-Src	breast:	n/a
48	chr6:29942083-29942133	GM12891	blood:	n/a
49	chr6:29941917-29941967	HRE	kidney:	n/a
50	chr6:29942083-29942133	HAEpiC	amniotic membrane:	n/a

No data

Variant related genes	Relation type
MICD	TF binding region
HCG9	TF binding region
MICD	CpG island
HCG9	CpG island

Extended variants
information (count: 67 )
Associated
traits (count: 113 )

Variant overlapped rSNPs/rCNVs (count:67 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs437941	chr6:29941769-29941770	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs420953	chr6:29941777-29941778	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs539012597	chr6:29941779-29941780	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs9260815	chr6:29941780-29941781	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
5	rs370672767	chr6:29941789-29941790	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs201210838	chr6:29941790-29941791	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs386698641	chr6:29941811-29941812	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs444252	chr6:29941813-29941814	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs201701401	chr6:29941814-29941815	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs9366750	chr6:29941829-29941830	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs372326808	chr6:29941850-29941851	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs116955874	chr6:29941851-29941852	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs2523948	chr6:29941857-29941858	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs2523947	chr6:29941873-29941874	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs185751751	chr6:29941884-29941885	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs189153927	chr6:29941918-29941919	Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs2523946	chr6:29941943-29941944	Weak transcription Bivalent Enhancer	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance disease
18	rs527391498	chr6:29941991-29941992	Weak transcription Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs3823352	chr6:29942033-29942034	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs3823353	chr6:29942045-29942046	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs3823354	chr6:29942051-29942052	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs3823355	chr6:29942083-29942084	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance disease
23	rs142877552	chr6:29942115-29942116	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
24	rs2844804	chr6:29942126-29942127	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs35406497	chr6:29942190-29942191	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs551687588	chr6:29942191-29942192	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs3823358	chr6:29942205-29942206	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs577248122	chr6:29942206-29942207	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs367573570	chr6:29942258-29942259	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs3823359	chr6:29942293-29942294	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs554285212	chr6:29942303-29942304	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs62388722	chr6:29942315-29942316	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs2523945	chr6:29942324-29942325	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs386698642	chr6:29942384-29942385	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs113540771	chr6:29942392-29942393	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs370204366	chr6:29942410-29942411	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs116253857	chr6:29942431-29942432	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs540762842	chr6:29942437-29942438	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs41265816	chr6:29942448-29942449	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
40	rs41265820	chr6:29942449-29942450	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs376966043	chr6:29942456-29942457	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs532072689	chr6:29942462-29942463	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs453375	chr6:29942487-29942488	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs62388723	chr6:29942489-29942490	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs554173042	chr6:29942496-29942497	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs393282	chr6:29942497-29942498	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs148741823	chr6:29942506-29942507	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
48	rs143723197	chr6:29942527-29942528	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
49	rs576146699	chr6:29942533-29942534	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
50	rs386698644	chr6:29942539-29942540	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:113)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Breast cancer	21509527	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Pancreatic cancer	17952125	CNVD
Rett syndrome	21593744	CNVD

Chromatin state (count:130 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:29933600-29942400	Weak transcription	Lung	lung
2	chr6:29934400-29944200	Weak transcription	Aorta	Aorta
3	chr6:29934800-29942600	Weak transcription	Brain Substantia Nigra	brain
4	chr6:29935400-29942600	Weak transcription	GM12878-XiMat	blood
5	chr6:29935400-29943400	Weak transcription	Small Intestine	intestine
6	chr6:29935600-29942600	Weak transcription	Brain Anterior Caudate	brain
7	chr6:29935600-29944800	Weak transcription	Dnd41	blood
8	chr6:29935800-29942800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
9	chr6:29936000-29942800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
10	chr6:29936200-29942000	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
11	chr6:29936200-29942400	Weak transcription	Right Atrium	heart
12	chr6:29936200-29942400	Weak transcription	Stomach Smooth Muscle	stomach
13	chr6:29936400-29942600	Weak transcription	HepG2	liver
14	chr6:29936400-29943000	Weak transcription	Psoas Muscle	Psoas
15	chr6:29936600-29942200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr6:29936600-29942400	Weak transcription	Skeletal Muscle Male	skeletal muscle
17	chr6:29936600-29942800	Weak transcription	Duodenum Smooth Muscle	Duodenum
18	chr6:29936600-29942800	Weak transcription	HSMMtube	muscle
19	chr6:29936800-29942800	Weak transcription	Sigmoid Colon	Sigmoid Colon
20	chr6:29937200-29942800	Weak transcription	Pancreatic Islets	Pancreatic Islet
21	chr6:29937800-29942800	Weak transcription	K562	blood
22	chr6:29938600-29942800	Weak transcription	Colonic Mucosa	Colon
23	chr6:29939200-29942600	Weak transcription	Adipose Nuclei	Adipose
24	chr6:29940600-29942000	Weak transcription	Pancreas	Pancrea
25	chr6:29940600-29942200	Weak transcription	Right Ventricle	heart
26	chr6:29940600-29942400	Weak transcription	Left Ventricle	heart
27	chr6:29940600-29942400	Weak transcription	Spleen	Spleen
28	chr6:29940600-29942600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
29	chr6:29940800-29942000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr6:29940800-29942400	Weak transcription	Gastric	stomach
31	chr6:29940800-29942600	Weak transcription	H9 Cell Line	embryonic stem cell
32	chr6:29940800-29942600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
33	chr6:29941600-29944400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
34	chr6:29941800-29943200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
35	chr6:29942000-29942200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
36	chr6:29942000-29942800	Enhancers	Pancreas	Pancrea
37	chr6:29942200-29942800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr6:29942200-29942800	Enhancers	Right Ventricle	heart
39	chr6:29942200-29943400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
40	chr6:29942200-29943400	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
41	chr6:29942400-29942600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
42	chr6:29942400-29942600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr6:29942400-29942600	Flanking Active TSS	Duodenum Mucosa	Duodenum
44	chr6:29942400-29942600	Active TSS	Stomach Smooth Muscle	stomach
45	chr6:29942400-29942800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
46	chr6:29942400-29942800	Enhancers	Left Ventricle	heart
47	chr6:29942400-29942800	Enhancers	Skeletal Muscle Male	skeletal muscle
48	chr6:29942400-29942800	Enhancers	Skeletal Muscle Female	skeletal muscle
49	chr6:29942400-29943000	Enhancers	Gastric	stomach
50	chr6:29942400-29943000	Enhancers	Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links